Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mejza

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Postepy Higieny I Medycyny Doswiadczalnej|July 27, 2001
[Selective cyclooxygenase 2 inhibitors (COX-2)]F Mejza, E Nizankowska
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 17, 2001
Safety of a specific COX-2 inhibitor in aspirin-induced asthmaA Szczeklik, E Nizankowska, G Bochenek, et al.
European Journal of Clinical Investigation|January 22, 2003
Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonistL Mastalerz, E Nizankowska, M Sanak, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Postepy Higieny I Medycyny Doswiadczalnej|July 27, 2001
[Selective cyclooxygenase 2 inhibitors (COX-2)]F Mejza, E Nizankowska
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 17, 2001
Safety of a specific COX-2 inhibitor in aspirin-induced asthmaA Szczeklik, E Nizankowska, G Bochenek, et al.
European Journal of Clinical Investigation|January 22, 2003
Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonistL Mastalerz, E Nizankowska, M Sanak, et al.
Pageof 1